These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Abnormal movements of the larynx. Diagnostic approach and therapeutic perspectives]. Angelard B; Feve A; Moine A; Fichaux P; Guillard A; Lacau St Guily J Ann Otolaryngol Chir Cervicofac; 1993; 110(3):125-8. PubMed ID: 8239331 [TBL] [Abstract][Full Text] [Related]
3. Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin. Fève A; Angelard B; Fénelon G; Logak M; Guillard A; Lacau Saint-Guily J Mov Disord; 1993 Apr; 8(2):217-9. PubMed ID: 8474494 [TBL] [Abstract][Full Text] [Related]
4. Treatment of intractable tardive lingual dyskinesia with botulinum toxin. Beckmann YY; Seçil Y; Saka S; Kuserli A; Çiftçi Y J Clin Psychopharmacol; 2011 Apr; 31(2):250-1. PubMed ID: 21364341 [No Abstract] [Full Text] [Related]
5. Valbenazine granted breakthrough drug status for treating tardive dyskinesia. Müller T Expert Opin Investig Drugs; 2015 Jun; 24(6):737-42. PubMed ID: 25809133 [TBL] [Abstract][Full Text] [Related]
6. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients]. Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440 [TBL] [Abstract][Full Text] [Related]
8. Tardive and idiopathic oromandibular dystonia: a clinical comparison. Tan EK; Jankovic J J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):186-90. PubMed ID: 10644785 [TBL] [Abstract][Full Text] [Related]
9. Articulatory impairment associated with tardive dyskinesia. Laporta M; Archambault D; Ross-Chouinard A; Chouinard G J Nerv Ment Dis; 1990 Oct; 178(10):660-2. PubMed ID: 1977872 [TBL] [Abstract][Full Text] [Related]
10. Not all that moves is tardive dyskinesia. Khot V; Wyatt RJ Am J Psychiatry; 1991 May; 148(5):661-6. PubMed ID: 1673323 [TBL] [Abstract][Full Text] [Related]
11. Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life. Sweet RA; Mulsant BH; Gupta B; Rifai AH; Pasternak RE; McEachran A; Zubenko GS Arch Gen Psychiatry; 1995 Jun; 52(6):478-86. PubMed ID: 7771918 [TBL] [Abstract][Full Text] [Related]
17. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III. van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS Am J Psychiatry; 1998 Apr; 155(4):565-7. PubMed ID: 9546009 [TBL] [Abstract][Full Text] [Related]
18. Successful therapy of tardive dyskinesia in a 71-year-old woman with a combination of tetrabenazine, olanzapine and tiapride. Koch HJ; Szecsey A; Vogel M; Fischer-Barnicol D Int J Clin Pract; 2003 Mar; 57(2):147-9. PubMed ID: 12661802 [TBL] [Abstract][Full Text] [Related]
19. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review. Goldman MB; Luchins DJ Hosp Community Psychiatry; 1984 Dec; 35(12):1215-9. PubMed ID: 6150891 [TBL] [Abstract][Full Text] [Related]